PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Yoon-Koo Kang Selected Research
Combination Drug Therapy (Combination Chemotherapy)
12/2008
A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer.
05/2008
Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
04/2008
A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.
07/2007
Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
01/2007
Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
08/2005
Docetaxel and cisplatin combination chemotherapy in metastatic breast cancer patients with previous exposure to anthracyclines.
10/2004
Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy.
Articles by Research Topic
Disease
13
Stomach Neoplasms (Stomach Cancer)
12/2008 - 07/2002
5
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2008 - 06/2005
4
Breast Neoplasms (Breast Cancer)
09/2006 - 06/2004
1
Hepatocellular Carcinoma (Hepatoma)
05/2008
1
Small Cell Carcinoma
10/2007
1
Neoplasms (Cancer)
01/2007
1
Neurofibromatosis 1 (Neurofibromatosis Type I)
06/2006
1
Gynecomastia
06/2005
1
Testicular Hydrocele
06/2005
1
Vomiting
01/2005
1
Syndrome
10/2004
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2003
1
Acinar Cell Carcinoma
07/2003
1
Colorectal Neoplasms (Colorectal Cancer)
02/2003
1
Lymphoma (Lymphomas)
01/2003
1
Rectal Neoplasms (Rectal Cancer)
04/2002
Drug/Important Bio-Agent (IBA)
8
Cisplatin (Platino)
FDA Link
Generic
04/2008 - 08/2002
7
capecitabine (Xeloda)
FDA Link
04/2008 - 07/2003
5
docetaxel (Taxotere)
FDA Link
12/2008 - 07/2002
5
imatinib (Gleevec)
FDA Link
07/2008 - 06/2005
4
Platinum
IBA
04/2008 - 05/2005
3
Fluorouracil (Carac)
FDA Link
Generic
04/2008 - 02/2003
2
irinotecan (Camptosar)
FDA Link
Generic
12/2008 - 04/2008
2
taxane
IBA
04/2008 - 08/2004
2
Leucovorin (Folinic Acid)
FDA Link
Generic
04/2008 - 02/2003
2
Paclitaxel (Taxol)
FDA Link
Generic
07/2007 - 05/2005
1
Etoposide (VP 16)
FDA Link
Generic
05/2008
1
Epirubicin (Ellence)
FDA Link
Generic
05/2008
1
oxaliplatin (Eloxatin)
FDA Link
04/2008
1
XELOX
IBA
04/2008
1
Platelet-Derived Growth Factor alpha Receptor
IBA
01/2008
1
ATP-Binding Cassette Transporters (ABC Transporters)
IBA
09/2006
1
Adenosine Triphosphate (ATP)
IBA
09/2006
1
Anthracyclines
IBA
08/2005
1
Carboplatin (JM8)
FDA Link
Generic
05/2005
1
ramosetron (Nasea)
IBA
01/2005
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2005
1
vinorelbine (Navelbine)
FDA Link
Generic
08/2004
1
Lamivudine (3TC)
FDA Link
12/2003
1
Hepatitis B Surface Antigens (HBsAg)
IBA
12/2003
1
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2003
1
doxifluridine
IBA
02/2003
1
Antigens
IBA
01/2003
1
SKI 2053R
IBA
08/2002
1
M-2 protocol
IBA
07/2002
Therapy/Procedure
7
Combination Drug Therapy (Combination Chemotherapy)
12/2008 - 10/2004
7
Drug Therapy (Chemotherapy)
04/2008 - 04/2002
1
Adjuvant Chemotherapy
06/2004